The global disease risk and health genetic test market is expected to grow at a significant CAGR during the forecast period (2021-2027). Health and disease risk genetic tests are used to determine a person's disease risk. These disorders can be treated well if identified preventive steps are adopted. It is a sort of genetic testing that examines single nucleotide polymorphisms (SNPs) in patients' DNA samples to determine chromosomal information that may cause or contribute to illnesses such as Alzheimer’s disease, celiac disease, Parkinson's disease, and others. In addition to providing insights about ancestry history and biogeographical origins, genetic tests can assist diagnose inherited illnesses such as Tay-Sachs disease and Huntington's disease with excellent accuracy.
Owing to the availability of increasingly affordable and accessible internet, the use of disease risk and health genetic tests online is growing significantly. People can now keep their genetic data on multiple websites. 23andme.com has made genetic data available through a simple saliva test kit. `The use of genetic tests outside of medical settings, such as home testing kits for at-home diagnosis or doctors' offices that give DNA tests without requiring a physician's order, is referred to as offline use of disease risk and health genetic test. In other words, it includes samples sent directly from customers in the form of self-collection kits.
Market Coverage
Competitive Landscape: 23andMe, Laboratory Cop. Of America Holdings (LabCorp), Quest Diagnostics, and Others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Disease Risk and Health Genetic Test Market Report Segmentation
By Type
• Celiac Disease
• Parkinson’s Disease
• Alzheimer Disease
• Others
By Application
• Offline
• Online
Global Disease Risk and Health Genetic Test Market by Region
North America
Europe
Asia-Pacific
Rest of the World